Clinical Trials
8 trialsNCT05876923 2026-04-09
The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
Mayo Clinic
Phase NA Recruiting
NCT07466498 2026-03-12
Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial
University of Washington
Phase 2 Not yet recruiting
NCT06983899 2026-02-06
Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial
Fred Hutchinson Cancer Center
Phase NA Recruiting
NCT05838716 2026-01-15
ViPER
University of Rochester
Phase 3 Recruiting
NCT07044310 2025-07-29
5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
Mayo Clinic
Phase 2 Recruiting
NCT06129851 2023-11-13
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer
University of Kansas Medical Center
Phase 2 Not yet recruiting
NCT02032121 2015-09-09
Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors
University of Miami
Phase NA Completed
NCT00587925 2009-02-26
Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed